Zopiclone hapten, antigen, antibody, colloidal gold chromatography detection device and application thereof
A technology for zopiclone and hapten, applied in the field of zopiclone hapten and colloidal gold chromatography detection device, can solve the problems of expensive equipment, false positive, complicated operation, etc., and achieve short detection time, strong specificity and easy operation simple effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0061] Example 1. Preparation of zopiclone hapten
[0062] The synthetic route to obtain the zopiclone hapten molecule by modifying the zopiclone intermediate (CAS: 43200-81-3) with succinic anhydride is as follows:
[0063]
[0064] Specifically, weigh 1.31 g of zopiclone intermediate (CAS: 43200-81-3) and 1.0 g of succinic anhydride, dissolve it completely with anhydrous pyridine, stir and react at 80°C overnight, and detect the reaction by thin layer chromatography (TLC). Process, after the reaction is complete, evaporate the solvent to dryness, add water to dissolve, extract 2-3 times with ethyl acetate, combine the organic phases, evaporate to dryness and pass column purification to obtain white solid H1, which is identified as the target product by MS, see Figure 4 .
Embodiment 2
[0065] Example 2. Preparation and Identification of Zopiclone Antigen
[0066] Preparation: Dissolve 0.1 mmol of the zopiclone hapten prepared in Example 1 in 2 mL of dimethylformamide (DMF), stir and add 0.2 mmol of dicyclohexylcarbodiimide (DCC) and 0.15 mmol of N-hydroxysuccinyl imine (NHS). Magnetic stirring was carried out overnight at 4°C. After centrifugation, the supernatant was liquid A, and 140 mg of BSA was weighed and dissolved in 10 mL of 0.1 mol / L phosphate buffered saline (PBS) (pH=8.0). Add DMF 1mL, stir and dissolve to prepare solution B, under magnetic stirring, gradually drop solution A into solution B, and react at 4°C for 12h. After centrifugation, the supernatant was taken, dialyzed with normal saline at 4°C for 3 days, and the dialysate was changed 3 times a day. The obtained whole antigen was dispensed into 0.5 mL centrifuge tubes at a concentration of 1 mg / mL. Store frozen in a -20°C freezer. At the same time, the zopiclone antigen with OVA as the ...
Embodiment 3
[0068] Example 3. Preparation of Zopiclone Antibody
[0069] 3.1 Animal immunity
[0070] Using the zopiclone immunization antigen obtained in Example 2, immunized four 6-week-old BALB / C mice with an immunization dose of 200 μg / mouse, and after three times of booster immunization, it produced antiserum.
[0071] 3.2 Cell fusion and cloning
[0072] Under sterile conditions, spleen cells were prepared from the spleen of immunized BALB / C mice, and the quantity ratio was adjusted according to the spleen cell: myeloma cell (SP2 / 0) = 9:1 for fusion. After more than 3 times of cloning culture and detection, A hybridoma cell line stably secreting anti-zopiclone monoclonal antibody was screened.
[0073] 3.3 Cell cryopreservation and recovery
[0074] The hybridoma cells were made into 5×10 6cells / mL for long-term storage in liquid nitrogen. When resuscitating, take out the cryopreservation tube from the liquid nitrogen irrigation, quickly put it into a warm water bath at 37°C, a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com